Skip to content

BioSig Technologies, Inc. STEX Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$506.66M-5,110%-$462.76M-4,376%-$39.85M-159%-$26.18M-49.6%-$9.72M+60.6%
$5M+3,719%$3.53M+1,779%$2.09M+734%$636K+104%$131K-63.1%
$80.4M+902%$57.1M+715%$8.29M-2.0%$8.96M-32.4%$8.02M-10.2%
-$19.5M-328%-$10.44M-119%-$7.89M-9.2%-$4.36M+54.5%-$4.56M+64.9%
$45.36M
$8.05M
$48.54M+517%$54.88M+1,065%$18.1M+143%$4.7M-55.1%$7.87M-35.1%
$4.04M+22.0%$21.08M+44,019%$11.34M+4,916%$1.62M$3.31M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does BioSig Technologies, Inc. generate?
BioSig Technologies, Inc. (STEX) generated -$19.5M in operating cash flow over the trailing twelve months.
Where does BioSig Technologies, Inc.'s cash flow data come from?
Every line is extracted from BioSig Technologies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.